A Non-resolving Skin Lesion in Hemodialysis Patient: Answers
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Hoppe B, Beck B, Milliner D
. The primary hyperoxalurias. Kidney Int. 2009; 75(12):1264-1271.
PMC: 4577278.
DOI: 10.1038/ki.2009.32.
View
2.
Bergstralh E, Monico C, Lieske J, Herges R, Langman C, Hoppe B
. Transplantation outcomes in primary hyperoxaluria. Am J Transplant. 2010; 10(11):2493-501.
PMC: 2965313.
DOI: 10.1111/j.1600-6143.2010.03271.x.
View
3.
Fargue S, Rumsby G, Danpure C
. Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1. Biochim Biophys Acta. 2013; 1832(10):1776-83.
DOI: 10.1016/j.bbadis.2013.04.010.
View
4.
Danpure C
. Advances in the enzymology and molecular genetics of primary hyperoxaluria type 1. Prospects for gene therapy. Nephrol Dial Transplant. 1995; 10 Suppl 8:24-9.
DOI: 10.1093/ndt/10.supp8.24.
View
5.
Harambat J, Fargue S, Acquaviva C, Gagnadoux M, Janssen F, Liutkus A
. Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int. 2009; 77(5):443-9.
DOI: 10.1038/ki.2009.435.
View